Role of the serotonergic system in the pathogenesis of major depressionand suicidal behavior

Neuropsychopharmacology

Volumn 21, Issue , 1999, Pages 99S-105S

  Mann, J John ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Antidepressant treatment; Brain; Cerebrospinal fluid; Depression; Functional brain imaging; Neuroendocrine; Platelet; Postmortem; Serotonin; Trait

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; BUSPIRONE; CLOMIPRAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FENCLONINE; FENFLURAMINE; IPSAPIRONE; MONOAMINE OXIDASE INHIBITOR; ONDANSETRON; PINDOLOL; PROLACTIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRYPTOPHAN;

BRAIN CORTEX; DEPRESSION; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG INHIBITION; DRUG RECEPTOR BINDING; ELECTROCONVULSIVE THERAPY; HUMAN; KNOCKOUT MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDAL BEHAVIOR;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; HUMANS; MOOD DISORDERS; RECEPTORS, SEROTONIN; SEROTONIN; SUICIDE;

EID: 0032821347     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00040-8     Document Type: Article

References (65)

1. Agren H, Reibring L, Hartvig P, Tedroff J, Bjurling P, Hörn-feldt K, Andersson Y, Lundqvist H, Längström B (1991): Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: A positron emission tomography study on patients and healthy volunteers. Acta Psychiat Scand 83:449-455
2. Asberg M, Bertilsson L, Martensson B, Scalia Tomba GP, Thorén P, Träskman-Bendz L (1984): CSF monoamine metabolites in melancholia. Acta Psychiat Scand 69:201-219
3. Baldwin D, Rudge S (1995): The role of serotonin in depression and anxiety. Int Clin Psychopharm 9:41-45
4. Bladina P, Goldfarb J, Green JP (1988): Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. Eur J Pharmacol 155:349-350
5. Blier P, De Montigny C, Chaput Y (1990): A role for the serotonin system in the mechanism of action of antidepressant treatments: Preclinical evidence. J Clin Psychiat 51(4 suppl): 14-21
6. Brown GL, Ebert MH, Goyer PF, Jimersom DC, Klein WJ, Bunney WE, Jr., Goodwin FK (1982): Aggression, suicide, and serotonin: Relationships to CSF amine metabolites. Am J Psychiat 139:741-746
7. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979): Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiat Res 1:131-139
8. Charney DS, Menkes DB, Heninger GR (1981): Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiat 38:1160-1180
9. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989): Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiat 46:587-599
10. Coccaro EF, Silverman JM, Klar HM, Horvath TB, Siever LJ (1994): Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiat 51:318-324
11. Coppen A, Prange AJ, Jr., Hill C, Whybrow PC, Noguera R (1972): Abnormalities of indoleamines in affective disorders. Arch Gen Psychiat 26:474-478
12. Coppen AJ (1969): Biochemical aspects of depression. Int Psychiat Clin 6:53-81
13. Costall B (1993): The breadth of action of the 5-HT3 receptor antagonists. Int Clin Psychopharm 8:3-9
14. Costall B, Domeney AM, Naylor RJ, Tyers MB (1987): Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92:881-894
15. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990): Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810-816
16. D'haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijse-mans M, Kaufman L (1992): SPECT imaging of serotonin2 receptors in depression. Psychiat Res Neuroimag 45:227-237
17. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger gR, Charney DS (1994): Serotonin and the neurobiology of depression: Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiat 51:865-874
18. Dencker SJ, Malm U, Roos B-E, Werdinius B (1966): Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J Neurochem 13:1545-1548
19. Depue RA, Spoont MR (1986): Conceptualizing a serotonin trait. A behavioral dimension of constraint. Ann NY Acad Sci 487:47-62
20. Ebert D, Ebmeier KP (1996): The role of the cingulate gyrus in depression: From functional anatomy to neurochemistry. Biol Psychiat 39:1044-1050
21. Ferrier IN, McKeith IG, Cross AJ, Perry EK, Candy JM, Perry RH (1986): Postmortem neurochemical studies in depression. Ann NY Acad Sci 487:128-142
22. Flory JD, Mann JJ, Manuck SB, Muldoon MF (1998): Recovery from major depression is not associated with normalization of serotonergic function. Biol Psychiat 43:320-326
23. Gaddum JH, Picarelli ZP (1957): Two kinds of tryptamine receptor. Br J Pharmacol 12:323-328
24. Gibbons RD, Davis JM (1986): Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels. Acta Psychiat Scand 74:8-12
25. Golden RN, Ekstrom D, Brown TM, Ruegg R, Evans DL, Haggerty JJ, Jr., Garbutt JC, Pedersen CA, Mason GA, Browne J, Carson SW (1992): Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects. Am J Psychiat 149:1168-1175
26. Hayakawa H, Shimizu M, Nishida A, Motohashi N, Yamawaki S (1994): Increase in serotonin 1A receptors in the dentate gyrus as revealed by autoradiographic analysis following repeated electroconvulsive shock but not imipramine treatment. Neuropsychobiology 30:53-56
27. Heninger GR, Charney DS, Sternberg DE (1984): Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiat 41:398-402
28. Higley JD, Thompson WW, Champoux M, Goldman D, Hasert MF, Kraemer GW, Scanlan JM, Suomi SJ, Linnoila M (1993): Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in Rhesus monkeys (Macaca mulatta). Arch Gen Psychiat 50:615-623
29. Kaplan RD, Mann JJ (1982): Altered platelet serotonin uptake kinetics in schizophrenia and depression. Life Sci 3:583-588
30. Kolb LC, Roizin L (1993): The First Psychiatric Institute. How Research and Education Changed Practice. Washington DC, American Psychiatric Press, Inc.
31. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Swain CJ, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sa-dowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NMJ (1998): Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640-1645
32. Lapin IP, Oxenkrug GF (1969): Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1:132-136
33. Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Wiesmann M, Osterheider M, Schulte HM (1990): 5-HT1A receptor responsivity in unipolar depression: Evaluation of ipsa-pirone-induced ACTH and cortisol secretion in patients and controls. Biol Psychiat 28:620-628
34. Mârtensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L (1989): Fluoxetine treatment of depression. Clinical effects, drug concentrations, and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid. Acta Psychiat Scand 79:586-596
35. Malison RT, Pelton G, Carpenter L, Sanacora G, Haroon E, Potenza M, Berman R, Baldwin RM, Seibyl JS, Price LH, Innis RB, Charney DS (1997): Reduced midbrain serotonin transporter binding in depressed vs. healthy subjects as measured by [123I]b-CIT SPECT. Soc Neurosci Abstr 23:1220
36. Mann JJ (1979): Altered platelet monoamine oxidase activity in affective disorders. Psychol Med 9:729-736
37. Mann JJ (1995): Violence and aggression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, pp 1919-1928
38. Mann JJ (1998a): Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J ECT 14:172-180
39. Mann JJ (1998b): The neurobiology of suicide. Nature Med 4:25-30
40. Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ (1989): Evidence for the 5-HT hypothesis of suicide: A review of postmortem studies. Br J Psychiat 155:7-14
41. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA (1996a): Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiat 153:174-182
42. Mann JJ, Malone KM, Sweeney JA, Brown RP, Linnoila M, Stanley B, Stanley M (1996b): Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 15:576-586
43. Mann JJ, McBride PA, Anderson GM, Mieczkowski TA (1992a): Platelet and whole blood serotonin content in depressed inpatients: Correlations with acute and lifetime psychopathology. Biol Psychiat 32:243-257
44. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo MD, Mieczkowski TA, Myers JE, Stanley M (1992b): Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiat 49:442-446
45. Mann JJ, McBride PA, Malone KM, DeMeo MD, Keilp J (1995): Blunted serotonergic responsivity in depressed patients. Neuropsychopharmacology 13:53-64
46. McBride PA, Brown RP, DeMeo M, Keilp J, Mieczkowski T, Mann JJ (1994): The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol Psychiat 35:295-308
47. McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry EK, Eccleston D (1987): 5-HT receptor binding in postmortem brain from patients with affective disorder. J Affect Disord 13:67-74
48. Meltzer HY, Arora RC, Baber R, Tricou B-J (1981): Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiat 38:1322-1326
49. Meltzer HY, Lowy MT (1987): The serotonin hypothesis of depression. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp 513-526
50. Meltzer HY, Perline R, Tricou BJ, Lowy M, Robertson A (1984): Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms. Arch Gen Psychiat 41:379-387
51. Mendels J, Frazer A, Fitzgerald RG, Ramsey TA, Stokes JW (1972): Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients. Science 175:1380-1382
52. Pazos A, Probst A, Palacios JM (1987): Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97-122
53. Perry CM, Markham A (1998): Sumatriptan. An updated review of its use in migraine. Drugs 56:889-922
54. Ramboz S, Saudou F, Amara DA, Belzung C, Dierich A, Lemeur M, Segu L, Misslin R, Buhot M-C, Hen R (1996): Behavioral characterization of mice packing the 5-HT1B receptor. NIDA Research Monograph 161:39-57
55. Rapport MM, Green AA, Page IH (1948): Crystalline serotonin. Science 108:329-330
56. Rocha BA, Ator R, Emmett-Oglesby MW, Hen R (1997): Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol Biochem Behav 57:407-412
57. Saudou F, Amara DA, Dierich A, Lemeur M, Ramboz S, Segu L, Buhot M-C, Hen R (1994): Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875-1878
58. Saudou F, Hen R (1994): 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem Int 25:503-532
59. Shopsin B, Friedman E, Gershon S (1976): Parachlorophenyl-alanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiat 33:811-819
60. Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M (1990): Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2:1144-1154
61. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TM, Friedman L, Rajkowska G (1998): Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression—Postmortem evidence for decreased serotonin activity. J Neurosci 18:7394-7401
62. Törk I (1990): Anatomy of the serotonergic system. Ann NY Acad Sci 600:9-35
63. van Praag HM, de Haan S (1979): Central serotonin metabolism and frequency of depression. Psychiat Res 1:219-224
64. Virkkunen M, Goldman D, Nielsen DA, Linnoila M (1995): Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiat Neurosci 20:271-275
65. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff CB, Bissette G, Kalogeras K, Karonen S-L, Lin-noila M (1994): CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiat 51:20-27